Revenue Cycle Management for Infusion in Infectious Disease Practices

Revenue cycle management for infusion in infectious disease practices covers the financial workflow from referral and eligibility through authorization, documentation, coding, drug and administration billing, claim submission, payment, denial resolution, and A/R follow-up. It must account for both cognitive infectious disease services and infusion-related activity, helping practices identify gaps that delay reimbursement or leave eligible revenue uncollected.

Infectious disease practices may manage office visits, hospital consults, OPAT, infusion services, specialty drugs, and contracted work within the same operation. Each activity can involve different documentation, coding, coverage, authorization, acquisition, and reimbursement considerations. A useful review connects the clinical workflow with the financial workflow so drug, administration, E/M, and related claims are handled consistently.

Revenue leakage can occur through under-leveled visits, missed drug or administration charges, incomplete documentation, authorization gaps, contract issues, denials, underpayments, and unpursued balances. Reporting by payer, service line, and provider can reveal payment trends, denial patterns, and A/R health. Tracing each issue back to documentation, charge capture, workflow, or contract terms helps identify corrective action.

Infusion claims management can include charge entry, coding review, claim scrubbing, submission, rejection clearing, and follow-up for E/M, infusion, and drug claims. The work may be provided as full claims management or overflow support. Reviewing the process inside the practice’s existing systems can help uncover backlogs, recurring errors, and handoff issues affecting reimbursement.

Eligibility and authorization are important financial controls for infusion and OPAT services. A review should confirm benefits, determine whether therapy falls under the medical or pharmacy benefit, and track prior authorization requirements for infusions, OPAT courses, and specialty drugs. Clear ownership and documentation reduce the risk that a practice provides covered services or acquires drugs without a workable reimbursement path.

An underpayment review compares payments with expected reimbursement for drug, administration, and E/M claims. It can identify short-pays, incorrect fee schedule application, and unit or NDC mismatches. Findings can then be disputed and tracked toward recovery. Reviewing patterns by payer or service type also helps practices determine whether a problem is isolated or connected to broader contract or billing workflow issues.

Yes. A practice launching an infusion suite or OPAT program should examine the workflow from referral to first dose and through final payment. Relevant areas include eligibility, authorization, documentation, coding, drug acquisition, charge capture, claims submission, payment reconciliation, denials, and A/R. A prioritized review can help leaders understand operational dependencies before the program becomes difficult to manage.

These resources are designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They are useful when evaluating infusion or OPAT operations, adding providers, reviewing reimbursement, investigating collection concerns, or assessing whether practice workflows support financial sustainability. Users can apply their own practice information rather than relying on generalized rates or margins.